Trevi Therapeutics (TRVI) PT Raised to $25 at Oppenheimer
Oppenheimer analyst Leland Gershall raised ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)